The National Centre for Cell Science (NCCS) is an autonomous institution of Department of Biotechnology, Ministry of Science & Technology, Government of India, for a mandate of basic research, teaching & training, and as a national repository for cell lines/hybridomas etc. The Centre is located in the midst of academically enriched environment of Savitribai Phule Pune University Campus, Pune.

NCCS invites applications for following posts on various extramural projects purely on temporary basis.

National Institute for Research in Environmental Health (NIREH), Bhopal, is one of the permanent institutes of the Indian Council of Medical Research (ICMR), a Government of India’s apex autonomous organization for bio-medical research in the country. Historical Indian Council of Medical Research, an apex national body in biomedical research in India, after the Methyl Isocynate (MIC) gas/toxic gas disaster in the night of 2nd and 3rd December, 1984 in Bhopal set up, a Coordinating Unit in 1985 and initiated several research programmes.

Indian Institute of Technology Guwahati, the sixth member of the IIT fraternity, was established in 1994. The academic programme of IIT Guwahati commenced in 1995. At present the Institute has eleven departments and five inter-disciplinary academic centres covering all the major engineering, science and humanities disciplines, offering BTech, BDes, MA, MDes, MTech, MSc and PhD programmes.

Post : Chief Technician

Institute of Life Sciences (ILS) was established in the year 1989 as an autonomous institute under the administrative control of Govt. of Odisha. In 2002, it was taken over by the Department of Biotechnology, Govt. of India. The Prime Minister of India Shri Atal Bihari Vajpayee dedicated the institute to the nation in July 2003.  Institute of Life Sciences has a broad vision of carrying out high-quality multidisciplinary research in the area of life sciences.

Indoco Remedies Ltd., is a fully integrated, research-oriented pharma company engaged in the manufacturing and marketing of Formulations and Active Pharmaceutical Ingredients (APIs). We have seven decades of presence in the Indian Pharma market and a strong foothold in the international market across 55 countries. Indoco, a USD 166 million company, employs around 6000 personnel, including over 300 skilled scientists.

WALK-IN-INTERVIEWS for our sterile manufacturing facility in Goa (Plant II)

Novotech is a leading Asia-Pacific biotech specialist CRO and consists of two operating brands, Novotech and PPC. Novotech is a clinical CRO with labs, phase I facilities, and drug development consulting services.  It has accumulated experience in over 3,700 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. Novotech is positioned to serve biopharmaceutical clients conducting clinical trials in Asia and globally.

PlasmaGen BioSciences is an Indian biopharmaceutical organization specializing exclusively in Plasma Protein and Speciality Care Therapy. Headquartered at Bengaluru- India, PlasmaGen has been making every effort to enhance these products' availability for the patients.  We realize a huge gap that exists between the availability of Plasma & Speciality Care products, and immense need of its therapies in India and other developing economies.

Wockhardt Ltd. is a global pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients.

Wockhardt is a Global Pharmaceutical and Biotechnology Organization required following professionals

Novotech is a leading Asia-Pacific biotech specialist CRO and consists of two operating brands, Novotech and PPC. Novotech is a clinical CRO with labs, phase I facilities, and drug development consulting services.  It has accumulated experience in over 3,700 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. Novotech is positioned to serve biopharmaceutical clients conducting clinical trials in Asia and globally.

PPD is a leading global contract research organization providing discovery, development and post-approval services as well as compound partnering programs. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations.

Post : CRA (Level II)

ICMR-National Institute of Malaria Research was established in 1977 as Malaria Research Centre, which was renamed as National Institute of Malaria Research in November 2005. ICMR-NIMR is one of the institutes of the Indian Council of Medical Research, an autonomous body under Department of Health Research, Ministry of Health & Family Welfare, Govt. of India.

Established on October 1, 1933 as University Department of Chemical Technology (popularly called UDCT) of the University of Bombay (now Mumbai), with the noble intention of advancing India's knowledge reserves in chemical science and technology, the Institute has grown to become a premier (deemed) university devoted to education, training, research and industrial collaboration in chemical engineering, chemical technology, applied chemistry, pharmacy, biotechnology and bio-processing.

TOSC International Pvt. Ltd. is one of the leading Pharmaceutical Companies in India, since 1985. With two manufacturing units in – Delhi and in the Excise free zone of Pantnagar (Rudrapur), we manufacture and supply a wide Therapeutic mix of products in the form of Tablets, Ointments, Syrups, Capsules, Nutraceuicals(Food Products), Injectables, Eye/Ear drops. The company has steadily made progress by successfully earning a reputed name among the Pharmaceutical Companies in India.

Applications are invited from eligible candidates for the following vacancies on contractual basis as shown in the table below under various programs implemented in the district under National Health Mission and for District Integrated Health and Family Welfare Society, Palghar.

Post: Pharmacist

Translational Health Science and Technology Institute is designed to be a dynamic and interactive organization with a mission to conduct innovative translational research across disciplines and professions to accelerate the development of concepts into products to improve human health. THSTI is a recognized R&D institute of the Manipal Academy of Higher Education (MAHE), New Delhi offering doctoral programs in biomedical science research.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, have evolved and transformed themselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Post: REGIONAL BUSINESS MANAGER

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80 plus countries providing over 1,500 products across various therapeutic categories in 50 plus dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Freshers from the batches of 2021,2022 & 2023 pass out/ Appearing candidates

Lupin has expanded and grown manifold since its inception in 1968. Today, Lupin employs 20,000 plus members in 11 countries across six continents, enabling safe and reliable delivery of medicines to our patients across 100 plus countries.

Walkin drive for medical representative in Lupin pharmaceuticals in Hyderabad and Chennai on 6th and 7th july 2023

Post: Medical Representative

Eli Lilly and Company (NYSE: LLY) announced new phase 2 data from retatrutide, Lillys investigational molecule being studied for the treatment of obesity. At 24 weeks, retatrutide (1 mg, 4 mg, 8 mg or 12 mg) met the primary endpoint for the efficacy estimand in participants living with obesity or overweight without diabetes, demonstrating a mean weight reduction up to 17.5% (41.2 lb. or 18.7 kg)ii. In a secondary endpoint, retatrutide demonstrated a mean weight reduction up to 24.2% (57.8 lb. or 26.2 kg)ii at the end of the 48-week treatment duration.